Skip to content

A split-mouth randomized controlled clinical trial: comparing piezosurgery versus burs for esthetic crown lengthening surgery

Comparison of piezosurgery and burs in esthetic crown lengthening surgery of altered passive eruption: A split-mouth randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20231002013
Enrollment
15
Registered
2023-10-02
Start date
2024-03-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Altered passive eruption Gummy smile Altered passive eruption Gummy smile Esthetic crown lengthening Crown lengthening surgery Piezosurgery

Interventions

Test quadrants will be receiving osseous surgery with piezosurgery,Control quadrants will be receiving osseous surgery with rotary diamond burs
Experimental Procedure/Surgery,Active Comparator Procedure/Surgery
Osseous surgery with piezosurgery,Osseous surgery with rotary diamond burs

Sponsors

Faculty of Dentistry, Thammasat University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Systemically healthy male or female, aged more than 18 years old. Diagnosed with gummy smile which defined by when more than 2 mm of gingiva is displayed during full smile. Presented with more than 20 teeth in the mouth including six maxillary anterior teeth with at least one premolar. Controlled periodontal disease with no deep periodontal pocket (>4 mm) on maxillary anterior teeth. Diagnosed with Altered passive eruption (APE) which is defined by the gingival margin located at a more coronal level in which the distance from the gingival margin to the CEJ is more than 2 mm in >2 of the maxillary anterior teeth in both right and left quadrants.

Exclusion criteria

Exclusion criteria: Presence of systemic conditions which contraindicated for oral surgery. Presence of uncontrolled or poorly controlled diabetes (HbA1c > 7%), insulin-dependent diabetes, osteoporosis, or immunosuppressed conditions. Presence of blood-related diseases. Alcoholism or drug abuse. Poor oral hygiene (%FMPS >25%). Currently undergoing orthodontic treatment. Use of medications known to cause drug-influenced gingival enlargement, anti-coagulants, anti-platelets, immunosuppressants, corticosteroids, or bisphosphonates. Confirmed pregnancy or lactation. Heavy smoker (>10cigarettes per day). Patients with history of periodontal surgery around maxillary anterior teeth within the past 12 months. Presence of extensive restorative or crowns on maxillary anterior teeth. Presence of severe malalignment/malposition of maxillary anterior teeth.

Design outcomes

Primary

MeasureTime frame
changes in mm between the position of the gingival margin between 6 weeks and 6 months following surgery mm

Secondary

MeasureTime frame
gingival display baseline and 6 months mm,radiographic bone changes baseline to 6 weeks and from 6 weeks to 6 months mm,supracrestal tissue dimension from baseline to 6 weeks and from 6 weeks to 6 months mm,patient-reported outcome measurements (PROMs) Before surgery, immediate following surgery, 6 months VAS 100,histological features Surgery Qualitative assessment ,Changes in mm between the position of the gingival margin between baseline and 6 weeks mm,Deviation in mm between the planned position and the actual gingival position between baseline and 6 weeks mm ,Lip mobility baseline and 6 months mm

Countries

Thailand

Contacts

Public ContactKitichai Janaphan

FACULTY OF DENTISTRY THAMMASAT UNIVERSITY

kitichai.jp@gmail.com0631896986

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026